HealthProves
Home/Fabrikanten/American Health Packaging
Fabrikant-profiel

American Health Packaging

Farmaceutisch bedrijf9 producten gevolgd
9
producten gevolgd
305.146
totaal meldingen
58
recalls geregistreerd
81,2%
ernstig algeheel
Producten
9 van 9 getoond
ProductGoedgekeurdMeldingen ↓Top signaalRecalls
196888.112Colitis ulcerosa2
198075.807Tardieve dyskinesie12
199538.413lage bloedsuiker21
—31.032Afstoting nierentransplantaat3
196520.833complicatie van sedatie0
—19.587Teruggeroepen product0
199815.829Virale mutatie geïdentificeerd2
200912.295trombose in apparaat3
19783.238hypernatriëmie15
Recall-geschiedenis · 50 geregistreerd
DatumKlasseRedenBedrijf
23 mei 2025IIPresence of foreign tablets/capsules.Teva Pharmaceuticals USA, Inc
5 mrt 2025IIFailed Dissolution SpecificationsGolden State Medical Supply Inc.
25 feb 2025IIFailed Dissolution Specifications - low dissolution resultsMYLAN PHARMACEUTICALS INC
3 sep 2024IIFailed Dissolution SpecificationsAscend Laboratories, LLC
18 jan 2024IIIMisprint on tabletDr. Reddy's Laboratories, Inc.
18 jan 2024IIIMisprint on tabletDr. Reddy's Laboratories, Inc.
6 apr 2023IICGMP deviations.PD-Rx Pharmaceuticals, Inc.
23 mrt 2023IIcGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc.
23 mrt 2023IIcGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.Preferred Pharmaceuticals, Inc.
20 mrt 2023IIcGMP DeviationsRemedyRepack Inc.
17 mrt 2023IICGMP Deviations: recalling drug products following an FDA inspection.Amerisource Health Services LLC
17 mrt 2023IICGMP Deviations: recalling drug products following an FDA inspection.Amerisource Health Services LLC
17 mrt 2023IICGMP Deviations: recalling drug products following an FDA inspection.Amerisource Health Services LLC
16 mrt 2023IICGMP DeviationsNorthwind Pharmaceuticals LLC
16 mrt 2023IICGMP DeviationsNorthwind Pharmaceuticals LLC
13 mrt 2023IIcGMP deviationsDirect Rx
13 mrt 2023IIcGMP deviationsDirect Rx
13 mrt 2023IIcGMP deviationsDirect Rx
7 feb 2023IICGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc.
7 feb 2023IICGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc.
7 feb 2023IICGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc.
5 dec 2022IISubpotent Drug: repackaged product was recalled by the manufacturer for subpotency.RemedyRepack Inc.
23 nov 2022IISubpotent DrugHeritage Pharmaceuticals Inc
29 jun 2022IICGMP DeviationsGlenmark Pharmaceuticals Inc., USA
3 mei 2022IIIFailed Dissolution Specifications: Nitrofurantoin Capsules recalled due to dissolution failure at 0-time of the repackaged lot. Drug release results were above specification at 0-time.American Health Packaging
12 apr 2022IIISubpotent Drug: Out of specification for assay.American Health Packaging
22 feb 2022IIImpurity failure at 0-time of the repackaged lot.American Health Packaging
20 dec 2021IIFailed Dissolution SpecificationsAmerican Health Packaging
17 sep 2021IIFailed Dissolution Specifications: results were above specification.American Health Packaging
29 jul 2021IILack of Assurance of SterilityTeva Pharmaceuticals USA
12 mei 2021IIIFailed Impurities/Degradation SpecificationsAmerican Health Packaging
26 apr 2021IILack of Assurance of SterilityTeva Pharmaceuticals USA
15 mrt 2021IICGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc.
15 feb 2021IIChemical contamination; Unknown brown residue adhering to the inside of one vial.Teva Pharmaceuticals USA
10 feb 2021IILack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.Teva Pharmaceuticals USA
10 feb 2021IILack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.Teva Pharmaceuticals USA
7 jan 2021IIFailed Dissolution SpecificationsAmerican Health Packaging
21 jul 2020ISuperpotent DrugFerring Pharmaceuticals Inc
21 jul 2020ISuperpotent DrugFerring Pharmaceuticals Inc
21 jul 2020ISuperpotent DrugFerring Pharmaceuticals Inc
10 jun 2020IIILabeling Not Elsewhere Classified: The statement Pharmacist: Dispense with the accompanying Medication Guide was not included on the carton label.American Health Packaging
19 mei 2020IIFailed dissolution specification - dissolution results of 59% (spec. NLT 85%) at the 24 month time point (end of shelf life).American Health Packaging
7 feb 2020IIGMP Deviations: Product bottle may be absent of desiccant.American Health Packaging
7 feb 2020IIGMP Deviations: Product bottle may be absent of desiccant.American Health Packaging
27 jan 2020IIGMP Deviations: Product bottle may be absent of desiccant.Teva Pharmaceuticals USA
27 jan 2020IIGMP Deviations: Product bottle may be absent of desiccant.Teva Pharmaceuticals USA
4 dec 2019IIFailed Dissolution Specifications: Low out of specification results obtained during stability testing.American Health Packaging
20 nov 2019IICGMP Deviations: Potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.American Health Packaging
1 nov 2019IICGMP Deviations: Presence of NDMA impurity detected in product.American Health Packaging
18 okt 2019IIFailed Dissolution Specification: Low out of specification dissolution results.Mylan Pharmaceuticals Inc.

Class I = redelijke kans op ernstige schade · Class II = tijdelijk of omkeerbaar · Class III = onwaarschijnlijk schadelijk.

Registratiestatus

Sommige producten van American Health Packaging zijn niet FDA-geregistreerd voor humaan gebruik. Voor ongeregistreerde stoffen (peptiden, SARMs zonder humane registratie) bestaat geen legitieme leverancier voor humaan gebruik. Het ontbreken van een inkooproute is de veiligheidsinformatie.